Search
ChatPaper
AI Writing
analysis
Analysis
编组
Open Data
more
More
RankingsMust ReadingJournal&ConferenceAI TRAI HistoryMaster Reading TreeXiaomai's Star TalentsTrajectoryTalentNDI TrackerOpenAI sign Language
VIPCreated with Sketch.

Randomized, double-blind, phase II study of tiragolumab plus atezolizumab versus placebo plus atezolizumab as first-line treatment for PD-L1-selected NSCLC (CITYSCAPE)

D. Rodriguez-Abreu,M. L. Johnson,M. Hussein,A. Scherz,M. Cobo, A. J. Patel,N. Secen, K. H. Lee,B. Massuti,S. Hiret,J. Chih-Hsin Yang, F. Barlesi, D. H. Lee, L. Paz-Ares,R. Hsieh, K. Miller,N. Patil, P. Twomey, V. Kapp,R. Meng,B. Chul Cho

SWISS MEDICAL WEEKLY（2020）

Cited 0|Views8
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined